Haoxi Health Technology Limited
HAO
$1.21
-$0.0198-1.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.04% | 37.70% | 71.88% | 97.39% | 137.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.04% | 37.70% | 71.88% | 97.39% | 137.58% |
| Cost of Revenue | 17.25% | 40.04% | 74.91% | 99.44% | 137.51% |
| Gross Profit | -19.89% | 4.02% | 33.39% | 69.17% | 138.71% |
| SG&A Expenses | 20.56% | 19.37% | 17.97% | 64.80% | 174.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.42% | 39.54% | 73.13% | 98.27% | 137.61% |
| Operating Income | -49.30% | -8.41% | 43.60% | 76.20% | 136.90% |
| Income Before Tax | -37.72% | -0.85% | 45.77% | 77.89% | 138.52% |
| Income Tax Expenses | 188.00% | 144.64% | 101.09% | 145.64% | 341.43% |
| Earnings from Continuing Operations | -76.71% | -29.40% | 33.18% | 66.06% | 120.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -76.71% | -29.40% | 33.18% | 66.06% | 120.98% |
| EBIT | -49.30% | -8.41% | 43.60% | 76.20% | 136.90% |
| EBITDA | -48.86% | -8.07% | 44.10% | 77.12% | 138.58% |
| EPS Basic | -73.15% | -30.94% | 21.09% | 47.76% | 88.57% |
| Normalized Basic EPS | -41.80% | -7.85% | 32.46% | 58.59% | 103.39% |
| EPS Diluted | -73.45% | -31.02% | 21.68% | 47.70% | 87.14% |
| Normalized Diluted EPS | -41.80% | -7.85% | 32.46% | 58.59% | 103.39% |
| Average Basic Shares Outstanding | 29.93% | 20.72% | 10.82% | 14.14% | 17.79% |
| Average Diluted Shares Outstanding | 29.93% | 20.72% | 10.82% | 14.14% | 17.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |